urotoday.com·1 min read·hard
PSMA PET Imaging for Radioligand Therapy Selection Across Prostate Cancer Disease States
✦AI Summary
This snippet introduces a discussion between Phillip Koo and Dr. Steve Cho regarding the use of PSMA PET imaging for selecting patients for radioligand therapy in prostate cancer treatment.
Phillip Koo: Hi, I'm Phillip Koo and welcome to UroToday's coverage of the USPCC meeting here in beautiful Deer Valley, Utah. We're here today with Dr. Steve Cho, who's the chair of nuclear medicine at the MD Anderson Cancer Center. First off, Steve,... [12715 chars]
healthscience
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in